News & Perspective

Vaccines are unavailable at least once a month, and 19% to 38% of shipments have temperature issues.

Most recipients produced antibodies, but 34% had no immune response to the outbreak strain.

Money could come from governments, industry, and others, with grants monitored by independent groups.

ACIP stops short of recommending routine use of group B vaccine in young people.

The 13-valent vaccine for young kids was shown more effective than the 23-valent version for older adults.

WHO-led malaria vaccine development group announces new goals and a wish list for future vaccines.